Clinical and technical factors associated with knee radiofrequency ablation outcomes: a multicenter analysis. Issue 4 (8th February 2021)

• Record Type: Journal Article
• Authors: Chen, Yian; Vu, To-Nhu H; Chinchilli, Vernon M; Farrag, Mohamed; Roybal, Alexandra R; Huh, Albert; Cohen, Zared O; Becker, Adam B; Arvanaghi, Babak; Agrawal, Mrinal; Ogden, Jacob; Cohen, Steven P
• Is Part Of: Regional anesthesia and pain medicine. Volume 46:Issue 4(2021)
• Page Start: 298
• Page End: 304
• Publication Date: 2021-02-08
• Subjects: treatment outcome -- diagnostic techniques and procedures -- chronic pain -- pain management -- nerve block; Conduction anesthesia -- Periodicals; Pain medicine -- Periodicals; 617.964
• DOI: 10.1136/rapm-2020-102017
• Languages: English
• ISSNs: 1098-7339

Abstract

Abstract : Background: There has been a surge in interest in radiofrequency ablation (RFA) of the genicular nerves over the past decade, with wide variability in selection, technique and outcomes. The aim of this study is to determine factors associated with treatment outcome. Methods: We retrospectively evaluated the effect of 23 demographic, clinical and technical variables on outcomes in 265 patients who underwent genicular nerve RFA for knee pain at 2 civilian and 1 military hospital. A primary outcome was designated as a > 30% decrease in average knee pain score lasting at least 3 months without cointerventions. Results: The overall rate of a positive response was 61.1% (95% CI 55.2% to 67.0%). In univariable analysis, larger electrode size (p=0.01), repeated lesions (p=0.02), having> 80% pain relief during the prognostic block (p=0.02), not being on opioids (p=0.04), having no coexisting psychiatric condition (p=0.02), having a lower baseline pain score (p=0.01) and having >3 nerves targeted (p=0.02) were associated with a positive outcome. In multivariate logistic analysis, being obese (OR 3.68, 95% CI 1.66 to 8.19, p=0.001), not using opioids (OR 0.35, 95% CI 0.16 to 0.77, p=0.009), not being depressed (OR 0.29, 95% CI 0.10 to 0.82, p=0.02), use of cooled RFA (OR 3.88, 95% CI 1.63 to 9.23, p=0.002) and performing multiple lesions at each neural target (OR 15.88, 95% CI 4.24 to 59.50, p<0.001) were associated with positive outcome. Conclusions: We identified multiple clinical and technical factors associated with treatment outcome, which should be considered when selecting patients for RFA treatment and in the design of clinical trials.